✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Gymnema evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Patient on insulin or sulfonylurea adding Gymnema — significant hypoglycemia risk [1]
⚠ Patient using Gymnema as sole diabetes treatment — it is ADJUNCTIVE [1] [2]
⚠ Patient using non-standardized Gymnema leaf — ensure ≥25% gymnemic acids [1]
⚠ Patient expecting rapid glucose control — allow 8–12 weeks for metabolic effects [2]
🥗 Food first — build your daily Typical 200–400 mg
Check the foods you regularly eat — the bar fills toward your daily target.
Gymnema leaf tea (1 cup)50 mg gymnemic acids (approximate)
Fresh Gymnema leaves (5 leaves, chewed)100 mg gymnemic acids (approximate)
Check your regular foods above
🔬 Lab interpreter
Recommended test
FBG / home glucose monitoring
FBG / home glucose monitoring
Reference range / target
Per diabetes management goals
Per diabetes management goals
Critical if on insulin or sulfonylureas [1].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Gymnema is a genuine glucose-lowering botanical with a unique dual mechanism: sweet taste receptor blockade + intestinal glucose absorption inhibition. Systematic review supports FBG (−20–30 mg/dL) and HbA1c (−0.3–0.6%) reduction as ADJUNCT therapy. The hypoglycemia risk with insulin/sulfonylureas is the critical safety teaching — never add Gymnema to secretagogues without monitoring [1] [2].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Insufficient data. Blood glucose effects require careful monitoring. Avoid without endocrinologist guidance [1].
👦 Pediatric: See guidance
Not studied in children. Avoid in pediatric diabetes without specialist guidance [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: BID with meals. For taste blocking: 10 min before meals [1].
💊 With food: With meals for glucose absorption inhibition [1].
🚫 Avoid: Combining with insulin or sulfonylureas without glucose monitoring. Using as sole antidiabetic agent [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Gymnema leaf extract (standardized 25% gymnemic acids)', 'preferred', '200–400 mg BID. Standardization critical for reliable dosing [1].'] | Standard | Check label | |
| ['Gymnema leaf powder', 'traditional', '2–4 g/day in water. Ayurvedic preparation. Variable gymnemic acid content [1].'] | Standard | Check label | |
| ['Gymnema leaf tea', 'mild', 'Chewing leaf or drinking tea temporarily blocks sweet taste. Therapeutic effect at tea doses uncertain [1].'] | Standard | Check label | |
| ['GS4 extract (water-soluble fraction)', 'clinical', 'Specific acid fraction used in some clinical trials. 400 mg/day [2].'] | Standard | Check label |
3 Common questions
Does Gymnema really block sweet taste? ▼
Yes. Gymnemic acids structurally resemble glucose and competitively bind to sweet taste receptors (T1R2/T1R3) on the tongue, blocking them for 30–60 minutes. This is a well-documented pharmacological effect, not placebo. The same molecular mimicry inhibits intestinal glucose transporters (SGLT1) [1].
Can Gymnema replace metformin? ▼
Can I use Gymnema to reduce sugar cravings? ▼
The sweet-taste blocking effect is real and dramatic. Some practitioners use Gymnema to help patients reduce sugar intake by making sweet foods unpalatable. However, no RCTs have studied this for weight management or sugar addiction specifically [1].
4 Clinical evidence
Strong
No single Cochrane review, but systematic reviews of multiple RCTs consistently show FBG and HbA1c reduction when Gymnema is added to standard antidiabetic therapy [2]. HIGH
Moderate
FBG reduction: multiple RCTs show FBG reduction of 20–30 mg/dL when added to metformin or sulfonylureas [2]. HbA1c: reduction of 0.3–0.6% in systematic review of adjunctive use [2]. Lipids: modest TC and TG reduction reported in 2 RCTs [1]. β-cell regeneration: demonstrated in animal models with streptozotocin-induced diabetes; human histological evidence absent [1]. MODERATE
Insufficient
5 Safety, toxicity & adverse events
Relative
⚠ Diabetes on insulin/sulfonylureas — additive hypoglycemia; monitor closely
⚠ Adjust antidiabetic medication only with clinician oversight
⚠ Pregnancy and lactation — limited data
🚩 Red flags
● Patient on glibenclamide/insulin adding Gymnema without dose adjustment — hypoglycemia [1]
● Patient with T1DM self-treating with Gymnema — inappropriate; needs insulin management [1]
● Patient expecting Gymnema to replace metformin — insufficient efficacy as monotherapy [2]
6 Interactions
Drug interactions
Insulin / Sulfonylureas Major
Mechanism: Gymnema stimulates insulin secretion + reduces glucose absorption; additive to exogenous insulin or secretagogues [1].
Effect: Hypoglycemia [1].
Action: Monitor glucose closely. May need antidiabetic dose reduction [1].
Metformin Moderate
Mechanism: Different mechanisms (Gymnema: absorption/secretion; metformin: hepatic output) [1].
Effect: Additive glucose lowering; generally beneficial [1].
Action: Monitor FBG. May allow metformin dose reduction over time [1].
Supplement synergies
Chromium · 200–400 µg chromium picolinate + standard Gymnema
Chromium enhances insulin sensitivity; Gymnema reduces glucose absorption. Complementary [1].
Chromium enhances insulin sensitivity; Gymnema reduces glucose absorption. Complementary [1].
Berberine · 500 mg berberine BID + 200 mg Gymnema BID
Different glucose-lowering mechanisms. Combined may provide broader metabolic benefit [1].
Different glucose-lowering mechanisms. Combined may provide broader metabolic benefit [1].
7 Regulatory
India (Ayush): Traditional Ayurvedic medicine for Madhumeha (diabetes). Listed in Ayurvedic Pharmacopoeia [1].
United States (FDA): Available as dietary supplement. No FDA-approved health claims [1].
European Union: Available as food supplement. No EMA monograph [1].
8 US supplement products
121
on-market products containing Gymnema (NIH DSLD)
Brands carrying Gymnema (90)
Click a brand to see its Gymnema products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Gymnema — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 15]. Available from: https://supplement.ge/ingredients/gymnema/
APA 7th: Pkhakadze, G. (2026). Gymnema — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/gymnema/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 4 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Gymnema — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/gymnema/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG